<DOC>
	<DOCNO>NCT01701141</DOCNO>
	<brief_summary>Major depressive disorder ( MDD ) often characterize anhedonia impaired ability modulate behavior function reward . However , neurobiology anhedonia reduce reward responsiveness remain largely unknown . Because dopamine ( DA ) play critical role goal-directed behavior reinforcement learning , DA dysregulation might play important role . In fact , several line evidence suggest down-regulation DA transmission might characterize depression vulnerability emergence depressive symptom . The current study seek elucidate role DA dysfunction MDD . We hypothesize MDD subject show reduce DAT bind potential , reduce reward learn probabilistic reward task , abnormal functional magnetic resonance imaging ( fMRI ) activation dorsal ventral striatal region instrumental learn task . This study include three session . The first take place Massachusetts General Hospital McLean Hospital 's Center Depression , Anxiety Stress Research . The aims session ( ) explain study ; ( b ) collect write informed consent , ( c ) ass subject 's eligibility . Following , another session ( either second third order ) take place MGH PET Imaging Laboratory . Participants complete PET scan probabilistic reward task design measure reward learn sensitivity reward . The radioactive tracer utilized 11C-altropane . Another session ( either second third order ) take place McLean Hospital Neuroimaging Center . Participants complete instrumental learn task fMRI , follow social reinforcement learn task implicit learn serial reaction time task upon completion scan . In instrumental learning task , participant opportunity earn money need learn , trial error , stimulus-outcome association . The social reinforcement learn task design investigate whether learn deficit MDD specific learn monetary incentive whether learn deficit global affect learn social reward punishment . Participants also complete implicit learn serial reaction time task , design exclude possibility global learn deficit MDD .</brief_summary>
	<brief_title>Depression Dopamine Transporter Function Study Using C-11 Altropane</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Anhedonia</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>Criteria All Subjects 1 . Written informed consent ; 2 . Both gender ethnic origin , age 18 45 ; 3 . Righthanded ( Chapman Chapman 1987 ) ; 4 . Absence medication least 3 week ; 5 . Absence pregnancy ; 6 . Absence current drug use ( cocaine , cannabinoids , opiate , amphetamine , benzodiazepine barbiturate ) assess urinary drug test . 7 . For woman , completion negative urine pregnancy test prior MRI scan , well negative STAT quantitative serum hCG test immediately prior radiopharmaceutical exposure ; 8 . Normal correctedtonormal vision hearing . Exclusion Criteria 1 . Pregnant currently breastfeed woman woman childbearing potential seek become pregnant suspect may pregnant . 2 . History current serious unstable medical illness , include cancer , cardiovascular , hepatic , renal , respiratory , endocrine , neurologic hematologic disease ; 3 . History seizure disorder ; 4 . Failure meet standard PET safety requirement ; 5 . Failure meet standard fMRI safety requirement ; 6 . Students employee supervise Investigators MGH , McLean Hospital Harvard University ; 7 . Absence fluency write spoken English ; 8 . History head injury ; 9 . History current use cocaine , stimulant , dopaminergic drug . 10 . Diabetes poor glucose control ; 11 . History current diagnosis dementia , score &lt; 26 Mini Mental Status Examination ( Folstein , 1975 ) screen visit ; 12 . Clinical laboratory evidence hypothyroidism currently take thyroid medication ; 13 . Currently take medication affect blood flow , e.g . certain blood pressure medication 14 . Evidence significant inconsistency selfreport . Criteria Specific MDD subject 1 . DSMIV diagnostic criterion MDD ( diagnose use SCID ) ; 2 . A baseline HRSD score ( Hamilton 1960 ) great equal 16 ( 17item version ) ; 1 . Subjects suicidal ideation outpatient treatment determine unsafe study clinician . These patient immediately refer appropriate clinical treatment ; 2 . History current diagnosis : learning developmental disorder ( include ADHD autism spectrum disorder ) , anorexia nervosa , cognitive disorder , somatoform factitious disorder , dissociative disorder , personality disorder , organic mental disorder , schizophrenia psychotic disorder , bipolar disorder , obsessive compulsive disorder ; simple phobia , social anxiety disorder generalize anxiety disorder allow secondary MDD . 3 . History substance dependence lifetime substance abuse within last 12 month ; 4 . History bulimia nervosa PTSD within past 2 year ; 5 . History current diagnosis dementia , score &lt; 26 Mini Mental Status Examination ( Folstein , 1975 ) screen visit ; 6 . Current use psychotropic drug ; 7 . Patients lifetime electroconvulsive therapy ( ECT ) ; 8 . Presence psychotropic medication least 2 week : 6 month dopaminergic drug ( include methylphenidate ) , 6 week fluoxetine , 6 month neuroleptic , 2 week benzodiazepine , 2 week antidepressant . Criteria Specific Control subject 1 . Absence medical , neurological , psychiatric illness ( include alcohol substance abuse ) , assess subject history structure clinical interview ( SCIDI/NP ) ; 2 . Absence medication least 3 week ; 1 . History current diagnosis DSMIV psychiatric illness ; 2 . First degree relative mood disorder psychosis ; 3 . History current use psychiatric medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Positron Emission Tomography ( PET )</keyword>
	<keyword>Magnetic resonance imaging ( MRI )</keyword>
	<keyword>reward</keyword>
	<keyword>stress</keyword>
	<keyword>learn</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Anhedonia</keyword>
</DOC>